PULMONARY PATHOLOGIC-CHANGES IN RATS EXPOSED TO MARIHUANA SMOKE FOR 1 YEAR

被引:22
作者
FLEISCHMAN, RW
BAKER, JR
ROSENKRANTZ, H
机构
[1] EG and G Mason Research Institute, Worcester
关键词
D O I
10.1016/0041-008X(79)90526-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Exposure of rats to marihuana or placebo smoke for periods up to 365 days was performed with an automatic inhalator. Δ9-Tetrahydrocannabinol (Δ9-THC) concentrations in the marihuana smoke were similar to those inhaled by man and were presented to the rats in a 50-ml puff volume of 2-sec duration and a 30-sec exposure interval followed by a 30-sec period of fresh air each minute (1 puff/min). By varying the number of puffs from three simultaneously smoked marihuana cigarettes (0.9 to 1.2% Δ9-THC), 8 to 10 Fischer rats simultaneously received a single daily Δ9-THC dose of 0.4, 0.8 or 1.5 mg/kg, 6-7 days per week for 365 days. All treatment groups contained 30 males and 30 females except for the high-dose group which had 50 males and 50 females. At each of the lower doses 2 60 (3%) of the animals died while at the higher dose 18 108 (17%) died. Twenty-five percent ( 15 60) of the placebo-smoked rats died primarily from carbon monoxide poisoning. No sham-smoked rats died. In deceased marihuana-smoked rats, organ congestion and focal petechial hemorrhages in the brain suggested circulatory failure. In contrast with an earlier 87-day inhalation study, pulmonary irritation progressed beyond a dose-related focal alveolitis or pneumonitis with the accumulation of yellow-brown alveolar macrophages admixed with a few neutrophils and mononuclear cells, to a spectrum of more pronounced inflammatory and focal proliferative changes. The development of focal granulomatous inflammation in the lung with giant cell forms of macrophages and cholesterol-like clefts were striking new developments in the marihuana-smoked rats, especially since these effects were dose related and nonreversible after a 30-day recovery period. © 1979.
引用
收藏
页码:557 / 566
页数:10
相关论文
共 29 条
[1]  
AGURELL S, 1971, ACTA PHARM SUEC, V8, P391
[2]   STUDIES ON PSYCHOCLINICAL ASPECTS OF LONG-TERM MARIHUANA USE IN 124 CASES [J].
CHOPRA, GS .
INTERNATIONAL JOURNAL OF THE ADDICTIONS, 1973, 8 (06) :1015-1026
[3]  
CUTTING M, 1974, CHEST, V66, P321
[4]  
CUTTING M, 1974, CLIN RES, V22, pA501
[5]   CHRONIC MARIHUANA INHALATION TOXICITY IN RATS [J].
FLEISCHMAN, RW ;
HAYDEN, DW ;
BRAUDE, MC ;
ROSENKRANTZ, H .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1975, 34 (03) :467-478
[6]   PULMONARY PARENCHYMAL CHOLESTEROL-ESTER GRANULOMAS IN PATIENTS WITH PULMONARY HYPERTENSION [J].
GLANCY, DL ;
FRAZIER, PD ;
ROBERTS, WC .
AMERICAN JOURNAL OF MEDICINE, 1968, 45 (02) :198-+
[7]  
GROSS P, 1972, AM J PATHOL, V28, P211
[8]  
HO BT, 1970, J PHARM PHARMACOL, V22, P537
[9]   INDUCTION OF ARYL HYDROCARBON HYDROXYLASE IN LUNGS OF MICE IN RESPONSE TO CIGARETTE-SMOKE [J].
HOLT, PG ;
KEAST, D .
EXPERIENTIA, 1973, 29 (08) :1004-1004
[10]   GAS CHROMATOGRAPHY MASS SPECTROMETRIC AND NUCLEAR MAGNETIC-RESONANCE SPECTROMETRIC STUDIES OF CARCINOGENIC POLYNUCLEAR AROMATIC-HYDROCARBONS IN TOBACCO AND MARIHUANA SMOKE CONDENSATES [J].
LEE, ML ;
NOVOTNY, M ;
BARTLE, KD .
ANALYTICAL CHEMISTRY, 1976, 48 (02) :405-416